Business
Eli Lilly takes aim at illicit market for its experimental weight-loss drug - cbsnews.com

What the report says
The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

Amule: Uganda Needs Stronger Marketing to Win More French TouristsDokolo Post
YOUR LEGACY LIGHTS THE PATH”: SSEKANDI SALUTES MUSEVENI ON HIS BIRTHDAYWatchdog Uganda
WHAT NEXT FOR SHAKIRA OKOOBAH? MISS TOURISM EAST AFRICA FIRST RUNNER-UP SETS HER SIGHTS ON COMMUNITY CHANGEWatchdog Uganda
Equity Group roadshow seeks to unlock cross-border trade and investmentNile Post
Prince Edward Rukidi Nyabongo I to Be Crowned Tooro King on September 29Watchdog Uganda